Label: BONDI SANDS BROAD SPECTRUM HYDRA UV PROTECT SPF 70 FACE FLUID- avobenzone, homosalate, octisalate, octocrylene lotion
- NDC Code(s): 70157-019-01
- Packager: Baxter Laboratories Pty. Ltd.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated January 26, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active Ingredients
- Purpose
- Uses
- Warnings
- Keep out of reach of children.
- When using this product
-
Directions
- Apply liberally 15 minutes before sun exposure. Use a water resistant sunscreen if swimming or sweating.
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
- Limit time in the sun, especially from 10 a.m.- 2 p.m.
- Wear long-sleeved shirts, pants, hats, and sunglasses.
- Children under 6 months: Ask a doctor.
- Other information
-
Inactive Ingredients
Water, Beeswax, C12-15 Alkyl Benzoate, Silica, PEG-15 Cocamine, Caprylyl Glycol, PEG-40 Stearate, Acrylates/Steareth-20 Methacrylate Copolymer, Caprylhydroxamic Acid, Glycerin, Carbomer, Aminomethyl Propanol, Phenoxyethanol, Sodium Carrageenan, Aloe Barbadensis Leaf Juice, Tocopheryl Acetate, Sodium Chloride.
- Questions?
- Product Packaging
-
INGREDIENTS AND APPEARANCE
BONDI SANDS BROAD SPECTRUM HYDRA UV PROTECT SPF 70 FACE FLUID
avobenzone, homosalate, octisalate, octocrylene lotionProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:70157-019 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE 30 mg in 1 mL OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE 100 mg in 1 mL HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE 120 mg in 1 mL OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE 50 mg in 1 mL Inactive Ingredients Ingredient Name Strength CAPRYLHYDROXAMIC ACID (UNII: UPY805K99W) PHENOXYETHANOL (UNII: HIE492ZZ3T) CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC) ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) WATER (UNII: 059QF0KO0R) ALOE VERA LEAF (UNII: ZY81Z83H0X) .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) PEG-15 COCAMINE (UNII: 8L6LB12TSJ) CARRAGEENAN (UNII: 5C69YCD2YJ) YELLOW WAX (UNII: 2ZA36H0S2V) AMINOMETHYLPROPANOL (UNII: LU49E6626Q) GLYCERIN (UNII: PDC6A3C0OX) SODIUM CHLORIDE (UNII: 451W47IQ8X) ETHYL ACRYLATE/METHACRYLIC ACID/STEARETH-20 METHACRYLATE COPOLYMER (UNII: EPA1872R1N) PEG-40 STEARATE (UNII: ECU18C66Q7) CAPRYLYL GLYCOL (UNII: 00YIU5438U) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:70157-019-01 1 in 1 CARTON 08/10/2021 1 40 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M020 08/10/2021 Labeler - Baxter Laboratories Pty. Ltd. (740537709)
